Healthpeak Properties presents a diversified REIT portfolio with 40% exposure to life sciences and strong 2026 FFO guidance of $1.71–1.75 per share. It maintains conservative leverage and investment-grade ratings, supporting a 6.2% monthly dividend with a 70% payout ratio. In contrast, Alexandria Real Estate is contracting its portfolio due to sector oversupply and negative re-leasing spreads, with 2026 FFO guidance at $5.80 per share. Healthpeak trades at a higher FFO multiple reflecting its growth and diversification, making it suitable for risk-averse investors, while Alexandria may appeal to those with higher risk tolerance.
Aecon Group Inc. and Arctic Gateway Group have signed a Memorandum of Understanding to collaborate on advancing infrastructure at the Port of Churchill and Hudson Bay Railway in Manitoba. This partnership aims to enhance Canada's northern trade corri...
Alexandria Real Estate Equities remains rated Hold as improved policy clarity and better asset sale prospects are offset by operational headwinds and weak leasing trends. The removal of the NIH indirect cost cap reduces some risks, but occupancy and ...
